Answers are grounded in this paper and cite their sources.
This narrative review examines radiomics and multimodal artificial intelligence for lung cancer diagnosis, staging, treatment response and prognosis. Evidence is organized by clinical decision points, validation maturity and implementation requirements. Clinical translation requires reproducible workflows, independent validation, calibration and demonstrated clinical utility. Current evidence remains predominantly retrospective and concentrated in non-small cell lung cancer, positioning radiomics as a potential complementary decision-support tool.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: